Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,444.25
(
0.58%
)
US TECH 100
28,717.20
(
1.51%
)
Dow Jones
49,693.20
(
-0.14%
)
Brent Oil
103.97
(
0.27%
)
Bitcoin
79,067.23
(
-0.27%
)
News Focus
News Focus
Post# of 405213
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

MinnieM

Send PM Follow Ignore
Followers 616
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

MinnieM

Re: ImmunoATX post# 120435

Friday, 08/28/2015 10:31:53 AM

Friday, August 28, 2015 10:31:53 AM

Post# of 405213
It looks like this is the big question with the Brilacidin-OM trial:
https://clinicaltrials.gov/ct2/show/NCT02324335?term=cellceutix&rank=3

Detailed Description:

This study will examine whether daily oral rinses with a solution containing brilacidin will prevent the occurrences of OM or lessen the severity of OM if it occurs. Patients will use an oral rinse 3 times daily for up to seven weeks during chemoradiation for head and neck cancer.



Hopefully, we see a reduced % of cases of OM in the Brilacidin arm along with fewer severe cases.

Welcome to the board.







To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote